WGRX logo

WELLGISTICS HEALTH INC

WGRXNASDAQ
πŸ† #5052 by market capUS Equity
$3.53β–² $0.98 (+27.72%)
After hours Β· at close
πŸ””
Track WGRX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 27.7%
7dβ–² 0.0%
14dβ–² 0.0%
30dβ–² 0.0%
ytdβ–Ό 81.7%
1yβ–Ό 92.6%
🏦Market Cap
$9M
Small Cap
πŸ“ˆRevenue Growth (YoY)
+28.7%
High Growth
πŸ“ŠGross Margin
-125.1%
Thin
πŸ’΅FCF Margin
-169.3%
Thin
βš–οΈP/S Ratio
1.1x
Cheap
Otter Score
60
Fair

Trading Snapshot

Day Range
$3.51 – $3.54
52-Week Range
$2.49 – $97.50
Volume
$1.69B
Avg Volume
$1.55B
Shares Outstanding
2.5M
Next Earnings
Nov 3, 2026

Fundamentals Snapshot

Annual Revenue
$23M
Last Q Revenue
$2M
P/E Ratio
-0.1
P/S Ratio
1.1x
EPS (TTM)
$-34.29
Dividend Yield
0.00%
Dilution (1yr)
+36.7%

Why Investors Own WGRX

  • βœ“High-growth profile β€” revenue up +14.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 64% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

WGRX logo

WELLGISTICS HEALTH INC

WGRX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$23Mβ–² +28.7% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
-41.3%β–Ό βˆ’523.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$81Mβ–² +1221.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$11Mβ–² +577.5% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.4Mβ–² +36.7% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$25Mβ–Ό βˆ’$645K YoY
StockOtter Β· stockotter.space

About WELLGISTICS HEALTH INC

Wellgistics Health, Inc. functions as a primary wholesaler and distributor of pharmaceutical products throughout the United States, catering to both drug manufacturers and independent retail pharmacies. Its extensive product catalog includes a variety of generic and brand-name pharmaceuticals, alongside over-the-counter healthcare and consumer merchandise. The company also delivers a suite of third-party logistics (3PL) services, encompassing warehousing, inventory control, pick-and-pack operations, and shipping solutions, specifically designed for small to mid-sized pharmaceutical producers. Furthermore, Wellgistics manages the DelivMeds platform, an integrated pharmaceutical hub that streamlines prescription transfers and offers essential backend clinical concierge support to its network of independent pharmacies. It also runs a specialized retail community service. Established in 2022 and headquartered in Tampa, Florida, the organization adopted its current name, Wellgistics Health, Inc., in October 2024, having previously operated as Danam Health, Inc.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Price Target

β“˜
Average Target
$4.30
β–² +21.9% Upside
High Target$5.28
Low Target$3.90
Based on 29 analysts

Latest News & Updates